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Bacteria-released components can modulate host innate immune response in the
absence of direct host cell–bacteria interaction. In particular, bacteria-derived outer
membrane vesicles (OMVs) were recently shown to activate host caspase-11-mediated
non-canonical inflammasome pathway via deliverance of OMV-bound lipopolysaccharide.
However, further precise understanding of innate immune-modulation by bacterial OMVs
remains elusive. Here, we present evidence that flagellated bacteria-released OMVs can
trigger NLRC4 canonical inflammasome activation via flagellin delivery to the cytoplasm of
host cells. Salmonella typhimurium-derived OMVs caused a robust NLRC4-mediated
caspase-1 activation and interleukin-1b secretion in macrophages in an endocytosis-
dependent, but guanylate-binding protein-independent manner. Notably, OMV-
associated flagellin is crucial for Salmonella OMV-induced inflammasome response.
Flagellated Pseudomonas aeruginosa-released OMVs consistently promoted robust
NLRC4 inflammasome activation, while non-flagellated Escherichia coli-released OMVs
induced NLRC4-independent non-canonical inflammasome activation leading to NLRP3-
mediated interleukin-1b secretion. Flagellin-deficient Salmonella OMVs caused a weak
interleukin-1b production in a NLRP3-dependent manner. These findings indicate that
Salmonella OMV triggers NLRC4 inflammasome activation via OMV-associated flagellin in
addition to a mild induction of non-canonical inflammasome signaling via OMV-bound
lipopolysaccharide. Intriguingly, flagellated Salmonella-derived OMVs induced more rapid
inflammasome response than flagellin-deficient Salmonella OMV and non-flagellated
Escherichia coli-derived OMVs. Supporting these in vitro results, Nlrc4-deficient mice
showed significantly reduced interleukin-1b production after intraperitoneal challenge with
Salmonella-released OMVs. Taken together, our results here propose that NLRC4
inflammasome machinery is a rapid sensor of bacterial OMV-bound flagellin as a host
defense mechanism against bacterial pathogen infection.
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Host immune system attempts to detect invasion of bacterial
pathogens via pattern-recognition receptors on tissue-resident
sentinel cells, such as macrophages (1). Recognition of bacterial
ligand by these receptors promptly results in the production of
proinflammatory cytokines, which then trigger host
inflammatory responses by recruiting more leukocytes from
the bloodstream to clear the invading pathogens (2). Among
the proinflammatory cytokines produced during the initial stage
of bacterial infection, interleukin (IL)-1b has a crucial role in
initiation of the inflammatory process (3). The maturation and
secretion of IL-1b requires formation of inflammasome multi-
protein complex (4). Upon bacterial infection, bacterial ligands
drive inflammasome complex assembly. This complex consists
mostly of sensor protein, adaptor protein, and procaspase-1,
leading to the generation of active caspase-1 (5). Caspase-1 then
processes inactive pro-IL-1b into an active form and facilitates
leaderless IL-1b secretion into the extracellular space.
Several cytosolic inflammasome sensor molecules detect
intracellular bacteria-specific ligands in direct or indirect ways
(2, 5). NOD-like receptor family, CARD domain-containing 4
(NLRC4) is the most professional sensor molecule that responds
to bacterial infections (6). NLRC4 monomer is assembled into
active oligomeric complex upon engagement by bacterial
flagellin-bound neuronal apoptosis inhibitory protein 5
(NAIP5), which is the actual sensor for bacterial flagellin (7).
Similarly, both NAIP1 and NAIP2 recognize type 3 secretion
system (T3SS) needle and rod proteins in Gram-negative
bacteria (8, 9), and this NAIPs–T3SS protein complex
promotes the assembly of NLRC4 inflammasome. Nlrc4-
deficient mice showed increased susceptibility to infection with
bacterial pathogens such as Salmonella typhimurium (10, 11),
which indicates that NLRC4 inflammasome confers innate
immune protection against pathogenic bacteria.
In addition to NLRC4, absent in melanoma 2 (AIM2) directly
detects cytosolic bacterial double-stranded DNA to form
AIM2 inflammasome (12). Caspase-11 recognizes intracellular
lipopolysaccharide (LPS), derived from invasive Gram-negative
bacteria, leading to the activation of non-canonical inflammasome
pathways (13, 14). In addition to this direct sensing of bacterial
ligands by inflammasome sensor molecules, some bacterial toxins
can indirectly drive inflammasome activation. For example, pore-
forming toxins from Staphylococcus aureus or Streptococcus
pneumoniae induce NLR family, pyrin domain-containing 3
(NLRP3)-mediated inflammasome activation (5). But some
bacterial toxins promote pyrin inflammasome signaling via Rho
GTPase inhibition (15).
Outer membrane vesicles (OMVs) are produced mostly from
Gram-negative bacteria by vesiculation process (16). The
physiological function of bacterial OMVs remains to be further
determined, but the generated OMVs eliminate toxic compounds
(e.g., misfolded proteins) to promote bacterial survival under
stress conditions (16). In addition, OMVs can increase bacterial
pathogenicity by delivering antibiotic resistance genes to other
bacteria and virulence factors to host cells (17). Hence, host
immune recognition of OMVs is beneficial for detection ofFrontiers in Immunology | www.frontiersin.org 2bacterial invasion and inhibition of the spread of bacterial
pathogenicity. Intriguingly, recent studies revealed that bacterial
OMVs can induce caspase-11-mediated non-canonical
inflammasome activation via deliverance of OMV-bound LPS
into the cytosol (18, 19). In this study, we present evidence that
OMVs from flagellated bacteria are able to trigger NLRC4-
mediated canonical inflammasome activation in a mainly
flagellin-dependent manner. This bacterial OMV-driven NLRC4
inflammasome signaling may provide an efficient host defense
mechanism as a rapid sens ing machinery against
bacterial infection.MATERIALS AND METHODS
Mice
C57BL/6 and Nlrp3−/− mice were obtained from The Jackson
Laboratory. Nlrc4−/− mice were obtained from Genentech
through Dr. Tatsuya Saitoh (Osaka University). Gbp2−/− mice
were provided by Korea Mouse Phenotyping Center. All mice
were bred at Yonsei University College of Medicine and
maintained under specific pathogen-free conditions. 9- to 12-
week old mice were used for the experiments. For some
experiments, mice were injected with Salmonella OMVs (50
µg) or phosphate-buffered saline (PBS) via the intraperitoneal
route. Protocols for the animal experiments were approved by
the Institutional Ethical Committee, Yonsei University College of
Medicine. All experiments were performed in accordance with
the approved guidelines of the Institutional Ethical Committee.
Reagents and Antibodies
LPS, ATP, nigericin, DOTAP liposomal transfection reagent,
proteinase K, cytochalasin D, MCC950, and OptiPrep density
gradient were purchased from Sigma-Aldrich. Pitstop2 was
obtained from Abcam. Flagellin purified from S. typhimurium
CDC 6516-60 (ATCC 14028) was purchased from InvivoGen.
CytoTox96 non-radioactive cytotoxicity assay kit was obtained
from Promega. The following antibodies were used for detecting
caspase-1 (Adipogen), NLRP3 (Adipogen), IL-1b (R&D
Systems), ASC (Santa Cruz Biotechnology), flagellin
(InvivoGen), OmpA (Biorbyt), and gasdermin D (Novus
Biologicals). Anti-NLRC4 antibody was prepared using mouse
NLRC4 peptide (AbFrontier).
Cell Culture
Mouse bone marrow-derived macrophages (BMDMs) were
prepared from mouse femurs as previously described (12).
Immortalized Asc−/− BMDMs were provided by Dr. E.S.
Alnemri (Thomas Jefferson University, Philadelphia, USA). All
BMDMs were maintained in L929-conditioned DMEM
supplemented with 10% fetal bovine serum and antibiotics.
Cell death was determined by extracellular release of lactate
dehydrogenase (LDH) using a CytoTox96 non-radioactive
cytotoxicity assay kit. The LDH release was calculated as
[extracellular LDH/(intracellular LDH + extracellular LDH)
× 100].November 2020 | Volume 11 | Article 581165
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Salmonella enterica serovar typhimurium strains, SL1344 and
14028s, were used in this study. Flagellin- or prgJ deletion
Salmonella mutants (fliC–fljB, prgJ, and fliC–fljB–prgJ) were
generated by homologous recombination and kindly provided
by Dr. F. Shao (National Institute of Biological Sciences, Beijing,
China). Pseudomonas aeruginosa strain PAO1 was kindly
provided by Dr. S.S. Yoon (Yonsei University College of
Medicine). Escherichia coli B (BL21) and DH5a strains were
obtained from RBC bioscience. Bacterial strains were grown
overnight in LB medium with shaking and aeration. Overnight-
cultured bacteria were normalized by bacterial number, diluted
1:50 with fresh LB medium and grown for an additional 6 or
1–12 h. Then, the bacterial suspension was centrifuged to pellet
the bacteria and further filtered using 0.2-µm syringe filter to
remove bacteria. The final filtrate was used for bacteria-free CS.
The prepared bacterial CS was added onto LB agar plate and
incubated overnight to confirm the absence of bacterial
contamination. To inactivate protein moiety in the bacterial CS,
CSs were heated at 98°C for 30 min (heat treatment) or treated
with proteinase K (10 µg/ml) at 37°C for 30 min and subsequently
boiled at 98°C for 30 min to eliminate proteinase K activity.
Preparation of Bacterial Outer Membrane
Vesicles
To prepare outer membrane vesicles, bacteria-free CSs (1L) were
concentrated to 25–50 ml by using the protein concentrator PES
100K MWCO (Thermo Fisher Sci) and ultracentrifuged at
150,000 × g at 4°C for 3 h. The pelleted fraction was washed
with PBS and re-ultracentrifuged. The final pellet was
resuspended with PBS (1 ml). The concentration of isolated
OMVs was determined using a BCA protein assay kit. Isolated
OMVs were analyzed using a Nanoparticle Tracking Analysis
system (NS300, Malvern Panalytical Ltd). The analyses were
performed with purified OMVs from at least three-independent
isolation. To further fractionate OMVs, OptiPrep gradients were
layered as: 1.7 ml 45%, 1.7 ml 40%, 1.7 ml 35%, 1.7 ml 30%,
1.7 ml 20%, and 1.7 ml 10%. Isolated OMVs (500 ml) were loaded
on top of the OptiPrep gradients. The gradients were
ultracentrifuged at 150,000 × g for 20 h at 4°C, and 1 ml of
each fraction was obtained. Obtained fractions were precipitated
for immunoblotting by methanol/chloroform extraction method.
In several experiments, isolated OMVs were heated at 98°C for
30 min (heat treatment) or treated with proteinase K (10 µg/ml)
at 37°C for 30 min and subsequently added with PMSF (1 mM)
to eliminate proteinase K activity.
Immunoblot Analysis
Cells were lysed in buffer containing 20 mM HEPES (pH 7.5),
0.5% Nonidet P-40, 50 mM KCl, 150 mMNaCl, 1.5 mMMgCl2, 1
mM EGTA, and protease inhibitors. Soluble lysates were
fractionated by SDS-PAGE and then transferred to PVDF
membranes. In some experiments, cell culture supernatants were
precipitated by methanol/chloroform as described previously (20)
and then immunoblotted. All the blots shown are representative
image of at least three-independent experiments.Frontiers in Immunology | www.frontiersin.org 3Assay of Inflammasome Activation
To induce a conventional NLRP3 inflammasome activation,
BMDMs were primed with LPS (0.25 µg/ml, 3 h), followed
with ATP treatment (2–2.5 mM, 30–45 min) (21). To induce a
non-canonical inflammasome activation, cells were treated with
Pam3CSK4 (1 µg/ml, 4 h), followed by the transfection of LPS
(2 µg/ml, 5 h) using a DOTAP (DT). Inflammasome activation
was determined by the presence of active caspase-1 p20 and
active IL-1b from culture supernatants in immunoblots and by
the extracellular IL-1b quantification using ELISA. To measure
extracellular levels of IL-1b or IL-6, culture supernatants were
assayed using an IL-1b- or IL-6-specific ELISA kit (BioLegend)
according to the manufacturer’s instructions.
Confocal Microscopy
Isolated OMVs were labeled by incubating with 1% (v/v)
Vybrant Dil (Thermo Fisher Scientific) at 37°C for 30 min.
Unbound dyes were removed by ultracentrifugation and PBS
washing three times. PBS was also incubated with dye in the
same way as the OMVs and used for negative control. After
treating with labeled OMVs, cells were fixed with 4% para-
formaldehyde. Fixed cells on coverslip were mounted using
ProLong Gold reagent with DAPI. The cells were then
examined using confocal microscopy (LSM700, Carl Zeiss,
Oberkochen, Germany).
Statistical Analysis
All values were expressed as the mean ± SEM of individual
samples. All the data were obtained from at least three-
independent experiments. Data were analyzed using Student’s
t-test or one-way analysis of variance (ANOVA) followed by
Dunnett’s post hoc test for comparison of all groups with control
group as indicated in the figure legend. The level of statistical
significance was set at p ≤ 0.05. Analyses were performed using
GraphPad Prism 5.RESULTS
Culture Supernatant From Salmonella
typhimurium Promotes NLRC4-Dependent
Caspase-1 Activation
Salmonella typhimurium is the most common enteric pathogen
causing gastroenteritis. To examine whether S. typhimurium-
secreted molecules can trigger host inflammasome signaling
pathways regardless of bacterial contact with host macrophages,
we used a transwell culture system (Figure 1A). As flagellin is the
major ligand for inflammasome activation during S. typhimurium
infection (22, 23), we tested flagellin-deficient (DfliC–fljB) S.
typhimurium as well as wild-type bacteria. Culture media from
wild-type and flagellin-deficient (DfliC–fljB) S. typhimurium in
the upper wells clearly drove a robust inflammasome activation of
mouse bone marrow-derived macrophages (BMDMs) in the
lower wells, as determined by the presence of cleaved caspase-1
(p20) and matured IL-1b in the supernatant (Figure 1B). To
further confirm the inflammasome-stimulating capacity ofNovember 2020 | Volume 11 | Article 581165
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bacteria-free culture supernatants (CS) from S. typhimurium
and treated them into BMDMs. Notably, CS from wild-type or
flagellin mutant S. typhimurium caused a marked caspase-1
activation (Figure 1C). This Salmonella CS-induced
inflammasome activation was dependent on NLRC4 and
apoptosis-associated speck-like protein containing a caspase
recruitment domain (ASC), which is a crucial adaptor protein
of the inflammasome complex (Figure 1D and Figure S1A).
However, activation was not dependent on NLRP3 (Figure 1E).
These findings indicated that Salmonella-secreted components areFrontiers in Immunology | www.frontiersin.org 4able to promote NLRC4-mediated inflammasome activation in
the absence of direct bacterial contact with host macrophages.
Culture Supernatant From Salmonella
typhimurium Activates Inflammasome
Signaling in a Flagellin- and prgJ-
Dependent Manner
To determine the bacterial components responsible for
Salmonella CS-induced NLRC4 inflammasome activation,
we first examined a potential role of protein present in the







FIGURE 1 | Culture supernatants from Salmonella typhimurium promotes NLRC4-dependent inflammasome activation. (A) Illustration of experimental scheme to
determine inflammasome activation in BMDMs by bacteria-secreted molecules using transwell plate. (B) Immunoblots from mouse BMDMs in the lower well
(A) incubated with wild-type (WT) or DfliC-fljB S. typhimurium SL1344 in the upper well (A, MOI 30) for 7 h. (C) Immunoblots from mouse BMDMs untreated or
treated with culture supernatant (CS, 1/33 or 1/10 volume of culture medium), derived from 6 h culture of WT or DfliC–fljB S. typhimurium, for 6 h. (D) Immunoblots
from Nlrc4+/+ or Nlrc4−/− mice BMDMs treated with WT or DfliC–fljB S. typhimurium CS (1/10) for 6 h. (E) Immunoblots from Nlrp3+/+ or Nlrp3−/− mice BMDMs
treated with WT or DfliC–fljB S. typhimurium CS (1/10) for 6 h, or primed with LPS (0.25 µg/ml, 3 h), followed by treatment with ATP (2.5 mM, 40 min).
(F) Immunoblots from mouse BMDMs incubated with S. typhimurium CS (1/20) with or without heat treatment (97°C, 30 min) or proteinase K treatment (10 µg/ml,
30 min), for 6 h. (G, H) Quantification of IL-1b (G) or IL-6 (H) in the supernatant of mouse BMDMs treated with S. typhimurium CS (1/20) as same as in (F). (n = 3,
one-way ANOVA) (I, J) Quantification of IL-1b (I) or IL-6 (J) in the culture supernatants of mouse BMDMs treated with WT, DfliC–fljB, or DfliC–fljB–prgJ
S. typhimurium CS (1/100) for 6 h. (n = 4, one-way ANOVA). (K) Immunoblots from mouse BMDMs treated with culture supernatant (CS, 1/100 or 1/20), derived
from 6 h culture of WT, DfliC–fljB, DfliC–fljB–prgJ S. typhimurium 14028s, for 6 h. (L) Immunoblots from mouse BMDMs treated with S. typhimurium flagellin (ST-FLA,
250 ng/ml) with or without premixing with DOTAP (DT) liposomal transfection reagent for 6 h or treated with LPS (0.25 µg/ml, 3 h), followed by ATP treatment (2.5
mM, 40 min). Culture supernatants (Sup) or cellular lysates (Lys) were immunoblotted with the indicated antibodies. Data were expressed as the mean ± SEM.
Asterisks indicate significant differences compared with S. typhimurium CS-treated group. (*P < 0.05, ***P < 0.001, n.s. not significant).November 2020 | Volume 11 | Article 581165
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and active IL-1b secretion (Figures 1F, G). Additionally, protein
degradation via proteinase treatment completely abrogated
S. typhimurium CS-induced inflammasome activation (Figures
1F, G). Indeed, proteinase treatment, but not heat treatment,
caused a complete degradation of bacterial proteins in the CS and
lysates (Figures S1B, C). However, neither heat inactivation nor
proteinase treatment impaired IL-6 production by Salmonella CS
(Figure 1H).
Flagellin and T3SS protein are the main stimulants for
NAIP-dependent NLRC4 inflammasome activation during
S. typhimurium infection (22, 23). We thus examined a
putative role of flagellin or PrgJ, a T3SS rod protein, in S.
typhimurium CS-induced inflammasome activation. CS from
flagellin-deficient (DfliC–fljB) Salmonella caused significantly
less IL-1b production than wild-type Salmonella CS (Figure
1I). Furthermore, S. typhimurium CS from flagellin/prgJ-
deficient mutants (DfliC–fljB–prgJ) induced remarkably
attenuated IL-1b secretion from BMDMs (Figure 1I).
However, both proteins were not required for CS-induced IL-6
production from BMDMs (Figure 1J). Consistent with these
findings, flagellin/prgJ-deficient Salmonella-derived CS failed to
induce a robust activation of caspase-1 and cell death in BMDMs
(Figure 1K and Figure S2).
To further confirm the role of flagellin or prgJ in the CS, we
directly treated a purified Salmonella flagellin protein into
BMDMs with or without DOTAP (N-[1-(2,3-Dioleoyloxy)
propyl]-N,N,N-trimethylammonium methyl-sulfate) liposomal
transfection agent. Consistent with the results of previous study
(22), cytosolic delivery of flagellin using DOTAP caused caspase-
1 activation in BMDMs (Figure 1L). Notably, 6 h treatment with
S. typhimurium flagellin alone also drove caspase-1 processing
(Figure 1L). This unexpected inflammasome activation by
recombinant flagellin required the expression of NLRC4 and
ASC but not of NLRP3 (Figures S3A–S3C). This result
suggested that Salmonella-released flagellin and T3SS rod
protein PrgJ are capable of inducing host NLRC4
inflammasome activation.
Salmonella typhimurium-Released Outer
Membrane Vesicles Promote Flagellin-
Mediated Caspase-1 Activation and IL-1b
Secretion in an Endocytosis-Dependent
Manner
To examine whether bacteria-secreted vesicle fractions mediated
inflammasome activation, we isolated pelleted fractions after
150,000 × g centrifugation of Salmonella CS. Intriguingly,
pelleted-vesicles from S. typhimurium CS still induced caspase-
1 activation and active IL-1b secretion (Figure 2A). We then
further isolated bacterial OMVs from Salmonella CS (Figure
S4A). Outer membrane protein A (OmpA) was present in
Salmonella OMV fractions (Figure 2B). The results of the
nanoparticle tracking analysis (Figure 2C) and transmission
electron microscopy (Figure 2D and Figure S4B) indicated
that S. typhimurium-released OMV size ranged from 50 to 200
nm. In addition, we confirmed the absence of bacterialFrontiers in Immunology | www.frontiersin.org 5contamination in the isolated OMV fractions or the CS
fraction (Figure S4C) by overnight culture in the LB agar plate
to exclude a possibility that free bacteria can affect the results.
Next, Salmonella-derived OMVs were treated into BMDMs to
examine the innate immune responses against bacterial OMVs.
Vybrant Dil-labeled OMVs were clearly detected in the cytosol of
BMDMs (Figure 2E), suggesting that bacteria-derived OMVs
can deliver bacterial components into the cytoplasm of host cells.
Of note, treatment with OMVs isolated from S. typhimurium
(SL1344 or 14028s) caused a robust caspase-1 activation and IL-
1b secretion in BMDMs (Figure 2F). S. typhimurium SL1344
OMV-triggered caspase-1 activation was markedly impaired by
flagellin deficiency (Figure 2G). Consistently, OMVs from
flagellin-deficient Salmonella SL1344 induced significantly less
IL-1b secretion than wild-type Salmonella OMVs in BMDMs
(Figure 2H). OMVs from flagellin-deficient S. typhimurium
strain 14028s also failed to trigger robust caspase-1 activation
and IL-1b production (Figures S5A, B). In contrast, flagellin
deficiency did not affect the Salmonella OMV-induced IL-6
production (Figure S5C).
To examine whether Salmonella OMVs did act to transport
bacterial proteins to the cytosol, we blocked phagocytosis using
cytochalasin D and clathrin-mediated endocytosis using Pitstop
2 (PS2), respectively. PS2 treatment, but not cytochalasin D
treatment, markedly inhibited inflammasome activation in
BMDMs in response to S. typhimurium-released OMVs and
CS (Figure 2I). PS2 treatment also significantly inhibited
cytosolic entry of labeled-OMVs (Figures 2J, K), indicating
that entry of S. typhimurium OMVs was facilitated by clathrin-
mediated endocytosis. Consistently, PS2 significantly reduced
Salmonella OMV-triggered IL-1b secretion (Figure 2L). These
findings support the hypothesis that Salmonella OMVs function
as a cargo carrier for cytosolic delivery of bacterial proteins
through clathrin-mediated endocytosis.
Salmonella typhimurium-Released Outer
Membrane Vesicles Promote NLRC4-
Dependent Inflammasome Activation
To elucidate the mechanisms underlying the inflammasome
activation by S. typhimurium-derived OMVs, we examined
which sensor molecule was associated with OMV-mediated
inflammasome activation. Previous studies found that OMVs
from Escherichia coli trigger caspase-11-mediated non-canonical
inflammasome activation via LPS delivery into the cytoplasm,
leading to NLRP3-dependent IL-1b secretion (18, 19).
Unexpectedly, the results indicated that S. typhimurium OMVs
were capable of inducing caspase-1 activation, even in Nlrp3-
deficient BMDMs (Figure 3A). As a control for caspase-11-
mediated non-canonical inflammasome signaling, cytosolic
delivery of LPS using DOTAP caused NLRP3-dependent
caspase-1 activation (Figure 3A). In contrast, S. typhimurium
OMV-induced caspase-1 activation was remarkably abolished in
Nlrc4- and Asc-deficient BMDMs (Figures 3B, C). This result
indicate that NLRC4 was a major sensor molecule for the
S. typhimurium OMVs. Flagellin-deficient Salmonella-released
OMVs caused very faint caspase-1 activation in macrophagesNovember 2020 | Volume 11 | Article 581165
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lacking OMVs apparently depended on the expression of NLRP3
in BMDMs (Figure 3D). Consistently, flagellin-deficient S.
typhimurium OMVs induced a weak IL-1b production in a
NLRP3-dependent manner (Figure S5D).
In support of these findings, S. typhimurium OMV-induced
IL-1b production was significantly impaired in Nlrc4-knockout
macrophages (Figure 3E). It was only very slightly reduced in
NLRP3-knockout macrophages (Figure 3F). But Salmonella
OMV treatment resulted in robust NLRC4- and NLRP3-
independent IL-6 production (Figures 3G, H). Taken together,Frontiers in Immunology | www.frontiersin.org 6these findings indicate that Salmonella-released OMVs can
trigger the activation of NLRC4/ASC-mediated inflammasome
signaling pathways in host macrophages.
Flagellated Bacteria-Released Outer
Membrane Vesicles Mediate NLRC4-
Dependent Inflammasome Signaling
To examine whether OMVs derived from bacteria other than
Salmonella can induce NLRC4-mediated inflammasome
activation, we tested the effects of the other Gram-negative






FIGURE 2 | Outer membrane vesicles from Salmonella typhimurium activate inflammasome signaling via receptor-mediated endocytosis. (A) Immunoblots from the
culture supernatants of mouse BMDMs treated with S. typhimurium CS, or supernatant (CS-Sup) or pellet (CS-Pel) from ultracentrifugation (150,000 × g, 18 h) of S.
typhimurium CS. (B) Immunoblots from wild-type (WT) or DfliC–fljB S. typhimurium CS, filtrates from Centricon concentration (Supplementary Figure S3A) and the
extract of OMVs. (C) Nanoparticle Tracking Analysis of OMVs isolated from WT or DfliC–fljB S. typhimurium. (D) Transmission electron microscopy of OMVs isolated
from wild-type S. typhimurium. Scale bar, 100 nm. (E) Representative confocal microscopy images of BMDMs treated with Vybrant Dil-labeled PBS or S. typhimurium
OMVs. Scale bar, 20 µm. (F) Immunoblots from mouse BMDMs treated with OMVs isolated from S. typhimurium SL1344 or 14028s (0.5 or 5 µg/ml) for 8 h or treated
with Pam3CSK4 (1 µg/ml, 4 h), followed by the transfection of LPS (2 µg/ml, 5 h) using a DOTAP (DT). (G) Immunoblots from mouse BMDMs treated with WT or DfliC–fljB
S. typhimurium (SL1344) OMV (1 or 5 µg/ml, 8 h). (H) Quantification of IL-1b in the culture supernatants of mouse BMDMs treated with WT, DfliC–fljB, or DfliC–fljB–prgJ
S. typhimurium (SL1344) OMVs (5 µg/ml, 8 h) (n = 7, one-way ANOVA). (I) Immunoblots from mouse BMDMs treated with S. typhimurium OMV (5 µg/ml, 6 h) in the
presence of cytochalasin D (5 µM) or Pitstop 2 (PS2, 10 µM), or treated with S. typhimurium CS (1/20) in the presence of PS2 (10 µM) pretreatment (10 min before
Salmonella CS treatment). (J) Representative confocal microscopy images of BMDMs treated with Vybrant Dil-labeled S. typhimurium OMVs (5 µg/ml, 6 h) in the presence
of Pitstop 2 treatment (10 µM, 30 min pretreat). Scale bar, 20 µm. (K) Relative Dil fluorescence intensity per DAPI signals of BMDMs as treated in (J). (n = 6, one-way
ANOVA). (L) Quantification of IL-1b in the culture supernatants of mouse BMDMs treated as in (I, left panel). (n = 3, one-way ANOVA). Culture supernatants (Sup) or
cellular lysates (Lys) were immunoblotted with the indicated antibodies. Data were expressed as the mean ± SEM. Asterisks indicate significant differences compared with
S. typhimurium CS-treated group. (*P < 0.05, ***P < 0.001).November 2020 | Volume 11 | Article 581165
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caused a robust caspase-1 activation and active IL-1b secretion
(Figure 4A). This P. aeruginosa OMV-driven inflammasome
activation depended on NLRC4, but not on NLRP3 (Figures 4B,
C). Consistent with these findings, P. aeruginosa OMV treatment
resulted in robust secretion of IL-1b in a NLRC4-dependent
manner (Figure 4D). Instead, NLRP3 deficiency caused a slight
reduction in IL-1b production by PseudomonasOMVs (Figure 4E).
Given that flagellin may be the main stimulus for Salmonella-
released OMV-induced NLRC4 inflammasome activation, we
examined the roles of OMVs from non-flagellated bacteria, such as
E. coli strains BL21 and DH5a. Unlike Salmonella or Pseudomonas
OMVs, E. coli (BL21 and DH5a)-released OMVs induced robust
caspase-1 activation only in NLRP3-expressingmacrophages (Figure
4F). In contrast, NLRC4 deficiency did not affect E. coliOMV-driven
caspase-1 activation (Figure 4G). Consistent with these results, non-
flagellated E. coli OMVs promoted NLRP3-dependent, but NLRC4-
independent, IL-1b secretion (Figures 4H, I). Furthermore, E. coliFrontiers in Immunology | www.frontiersin.org 7OMV-induced inflammasome activation was blocked by NLRP3-
selective inhibitor MCC950 (Figure S6). These findings indicate that
non-flagellated bacteria-released OMVs induce NLRP3
inflammasome activation probably via triggering caspase-11-
mediated non-canonical inflammasome signaling. In contrast,
flagellated bacteria-released OMVs can facilitate canonical NLRC4
inflammasome pathways.
Salmonella typhimurium Outer Membrane
Vesicles-Contained Flagellin Triggers
Inflammasome Activation in a GBP2-
Independent Manner
As the results indicated, flagellin in the OMVs had a pivotal role
in Salmonella OMV-induced caspase-1 activation. We thus
examined whether flagellin was indeed located in the OMVs
derived from Salmonella culture. Isolated OMVs were further
fractionated using an OptiPrep density gradient medium.
Flagellin was detected in the same fraction as in OmpA, anA B D
E F G H
C
FIGURE 3 | Salmonella-released outer membrane vesicles promotes NLRC4-dependent inflammasome activation. (A, B) Immunoblots from Nlrp3+/+ or Nlrp3−/−
(A) or Nlrc4+/+ or Nlrc4−/− (B) mice BMDMs treated with S. typhimurium OMVs (3 or 10 µg/ml, 6 h, A; 5 or 12.5 µg/ml, 6 h, B), or treated with Pam3CSK4 (1 µg/ml,
4 h), followed by the transfection of LPS (1 µg/ml, 6 h) using a DOTAP (DT). (C) Immunoblots from Asc+/+ or Asc −/− immortalized BMDMs treated with S.
typhimurium OMVs (5 or 12.5 µg/ml, 6 h), or primed with LPS (1 µg/ml, 6 h), followed by the treatment with nigericin (5 µM, 40 min). (D) Immunoblots from Nlrp3+/+
or Nlrp3−/− mice BMDMs treated with DfliC–fljB S. typhimurium OMVs (10 µg/ml) for 6 h. (E, F) Quantification of IL-1b in the culture supernatants of Nlrc4+/+ or
Nlrc4−/− (E) or Nlrp3+/+ or Nlrp3−/− (F) mice BMDMs treated with S. typhimurium OMVs (1 or 7 µg/ml, E; 10 µg/ml, F) for 8 h, or treated with Pam3CSK4 (1 µg/ml,
3 h), followed by the transfection of LPS (2 µg/ml, E; 1 µg/ml, F) for 6 h. (n = 3) (G, H) Quantification of IL-1b in the culture supernatants of Nlrc4 +/+ or Nlrc4−/−
(G) or Nlrp3+/+ or Nlrp3−/− (H) mice BMDMs treated with as same as in (E, F). (n = 3) Culture supernatants (Sup) or cellular lysates (Lys) were immunoblotted with
the indicated antibodies. Data were expressed as the mean ± SEM. Asterisks indicate significant differences compared with the group in the Nlrp3+/+ cells.
(*P < 0.05, ***P < 0.001).November 2020 | Volume 11 | Article 581165
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present in the S. typhimurium-released OMVs. Moreover,
flagellin was observed in the low density fraction of bacterial
CS, but not of OMVs (Figure 5A), suggesting that isolated
OMVs contain no or very little free flagellin outside OMVs.
Nevertheless, to further confirm whether flagellin is present as
inserted forms in the OMV membrane or inside OMVs, isolated
OMVs were subjected to heat and proteinase K treatment.
Flagellin in the OMVs was almost intact against heat- and
proteinase treatment (Figure 5B), while flagellin in the
bacterial CS was completely degraded by proteinase treatment
(Figure S1B). Indeed, heat treatment significantly impaired
bacterial CS-induced inflammasome activation (Figures 1F,
G). Similarly, heat-inactivation of recombinant Salmonella
flagellin protein greatly impaired inflammasome activation
(Figure 5C). However, heat treatment did not inhibit rather
increase S. typhimurium OMV-triggered caspase-1 activation
and IL-1b secretion (Figures 5D, E). These results
demonstrate that OMVs may function as a cargo for cytosolic
delivery of flagellin against heat- or proteinase-induced damages.
Guanylate-binding proteins (GBPs) are required for bacterial
OMV-mediated non-canonical inflammasome activation in the
previous studies (19, 24). The results suggest that GBP2 and
GBP5 facilitate the release of LPS from OMVs, which enables the
interaction between LPS and caspase-11. In this context, we
investigated the potential involvement of GBP2 on S.
typhimurium OMV-induced inflammasome activation. GBP2
deficiency clearly abrogated caspase-1 activation and IL-1b
secretion by OMVs isolated from E. coli culture (Figures 5F,
G). In contrast to E. coli-derived OMVs, wild-type Salmonella-
derived OMVs caused similar levels of caspase-1 processing and
IL-1b production from Gbp2-deficient macrophages (Figures
5F, H). However, flagellin-deficient (DfliC–fljB) S. typhimurium
OMVs led to a weak GBP2-dependent IL-1b production (Figure
S7), indicating that S. typhimurium OMVs are also able to
mediate non-canonical inflammasome activation to a lesser
degree. These results demonstrate that E. coli OMVs and
flagellin-deficient S. typhimurium OMVs can trigger GBP2-
NLRP3-mediated non-canonical inflammasome activation.
In addition, we further examined inflammasome-activating
capacity of proteinase-treated S. typhimurium OMVs to exclude a
possibility that free flagellin contamination in the isolated OMVs
may affect our results. Proteinase-treated OMVs caused a similar
extent of caspase-1 activation to intact OMVs (Figure 5I).
Furthermore, proteinase-treated OMVs induced a robust caspase-
1 activation regardless of MCC950 treatment (Figure 5J). These
observations further support that S. typhimuriumOMVs can trigger
NLRC4 inflammasome signaling via OMV-associated flagellin.
Salmonella typhimurium Outer Membrane
Vesicles Drive More Rapid NLRC4-
Dependent Inflammasome Activation in a
Flagellin-Dependent Manner Than E. coli-
Derived Outer Membrane Vesicles
To further evaluate the role of flagellin for inflammasome-
stimulating potential of Salmonella OMVs, we examined time-Frontiers in Immunology | www.frontiersin.org 8dependent inflammasome activity induced by wild-type and
flagellin-deficient S. typhimurium OMVs. We found that
flagellin-deficient Salmonella-released OMVs caused a delayed
and weaker inflammasome activation than wild-type S.
typhimurium OMVs in BMDMs (Figures 6A, B). Interestingly,
flagellin-deficient Salmonella OMVs induced a significant weaker
cell death of macrophages, as measured by LDH release, until 8 h
post OMV treatment compared to wild-type Salmonella OMVs
(Figure 6C). However, prolonged (16 h) treatment with Salmonella
OMVs caused similar IL-1b production and pyroptotic cell death
irrespective of flagellin expression (Figures 6B, C).
Then, we checked time-dependent inflammasome response
from macrophages upon treatment with Salmonella- or E.coli-
derived OMVs. S. typhimurium OMVs promoted rapid caspase-1
activation as early as 2 h post treatment, whereas E. coliOMVs did
not induce robust caspase-1 activation until 8 h-treatment (Figure
6D). These findings suggest that S. typhimurium OMV-associated
flagellin can trigger more rapid host inflammasome activation
than E. coli OMV-bound LPS. Instead, E. coli OMVs promoted
stronger gasdermin D cleavage (Figure 6D), as determined by the
presence of cleaved GSDMD (NT) in the cytosol, and pyroptotic
cell death (Figure 6E) than S. typhimurium OMVs at 8 h-
treatment to macrophages. These results propose that NLRC4
inflammasome machinery is a critical sensor for rapid detection of
flagellated bacteria-released OMVs as a host defense mechanism,
whereas non-flagellated bacteria-induced caspase-11 non-
canonical inflammasome signaling rather contributes to
pyroptosis in response to bacterial OMV-delivered LPS.
To determine in vivo role of NLRC4 against S. typhimurium–
released OMVs, we intraperitoneally injected bacterial OMVs
into mice. Analysis of peritoneal lavage contents from mice
revealed that intraperitoneal challenge with S. typhimurium-
released OMVs caused robust IL-1b production (Figure 6F).
Nlrc4-deficient mice showed significantly reduced IL-1b
production (Figure 6F) after S. typhimurium OMV challenge.
Interestingly, NLRP3 deficiency significantly reduced IL-1b
production in the peri toneal lavage of mice after
intraperitoneal injection of Salmonella-derived OMVs (Figure
6G). Flagellin-deficient S. typhimurium OMVs also caused
NLRP3-dependent IL-1b production from mice (Figure 6H),
indicating that Salmonella-derived OMVs can facilitate both
NLRC4- and NLRP3-mediated inflammasome activation in
mice. However, IL-6 production was promoted regardless of
NLRC4 and NLRP3 presence in the peritoneal lavage of mice
upon S. typhimurium OMV challenge (Figures 6I, J). These
findings further support the hypothesis that Salmonella-derived
OMVs can induce in vivo NLRC4-mediated canonical
inflammasome activation in addition to caspase-11 non-
canonical inflammasome activation.DISCUSSION
Gram-negative bacteria-released OMVs can facilitate the spread
of bacterial pathogenicity through delivery of virulence factorsNovember 2020 | Volume 11 | Article 581165
Yang et al. NLRC4 Inflammasome Activation by OMVand antibiotic resistance genes (16). Bacterial OMVs can also
trigger host innate sensing machinery (e.g., inflammasome
pathways), which helps to increase bacterial clearance (17). In
particular, bacteria-released OMVs promote caspase-11-
mediated non-canonical inflammasome responses via OMV-
bound LPS (18, 24, 25). OMV-mediated intracellular delivery
of LPS results in the activation of caspase-11, a cytosolic LPS
sensor, with the help of GBPs (19). Active caspase-11 then
induces gasdermin D pore formation in the plasma membrane,
which leads to potassium efflux and subsequent NLRP3
inflammasome activation (26). In this context, bacterial OMVs
can induce IL-1b secretion in a caspase-11-mediated indirect
manner, as described above. However, our study is the first to
find that bacterial OMVs can directly trigger host NLRC4-Frontiers in Immunology | www.frontiersin.org 9mediated canonical inflammasome activation by delivering
bacterial flagellin into the cytoplasm of host cells.
Our results indicate that inflammasome activation by
OMVs from flagellated bacteria such as S. typhimurium and P.
aeruginosa was markedly abolished in Nlrc4-deficient macrophages,
but slightly decreased in Nlrp3-deficent cells. Consistently,
OMVs released from S. typhimurium lacking flagellin and T3SS
protein prgJ failed to induce strong inflammasome activation.
These findings further support the potential role of bacterial
OMV-associated flagellin for the NLRC4 inflammasome
activation. Bacterial flagellin is essential for bacterial motility
and invasion, and thus is considered a significant virulence factor.
Additionally, flagellin is the most abundant protein in the
secreted fraction of S. typhimurium cultures (27). PreviousA B D E
F G IH
C
FIGURE 4 | Flagellated bacteria-released outer membrane vesicles trigger NLRC4-dependent inflammasome activation. (A) Immunoblots from mouse BMDMs
treated with OMV (0.5 or 3 µg/ml) isolated from Pseudomonas aeruginosa PAO1 for 8 h. (B) Immunoblots from Nlrc4+/+ or Nlrc4−/− mice BMDMs treated with
P. aeruginosa OMV (1 or 7 µg/ml) for 8 h. (C) Immunoblots from Nlrp3 +/+ or Nlrp3−/− mice BMDMs treated with P. aeruginosa OMV (5 µg/ml) for 8 h.
(D, E) Quantification of IL-1b in the culture supernatants of Nlrc4+/+ or Nlrc4−/− (D) or Nlrp3+/+ or Nlrp3−/− (E) mice BMDMs treated with P. aeruginosa OMV (1 or
7 µg/ml, D; 5 µg/ml, E) for 8 h, or treated with Pam3CSK4 (1 µg/ml, 3 h), followed by the transfection of LPS (2 µg/ml, D; 1 µg/ml, E) for 6 h. (n = 3) (F) Immunoblots
from Nlrp3+/+ or Nlrp3−/− mice BMDMs treated with E. coli BL21 or DH5a OMVs (5 µg/ml) for 8 h. (G) Immunoblots from Nlrc4+/+ or Nlrc4−/− mice BMDMs treated
with E. coli BL21 OMVs (1 or 5 µg/ml) for 8 h. (H, I) Quantification of IL-1b in the culture supernatants of Nlrp3+/+ or Nlrp3−/− (H) or Nlrc4+/+ or Nlrc4−/− (I) mice
BMDMs treated with E. coli BL21-derived OMVs (5 µg/ml, H; 1 or 5 µg/ml, I) or DH5a-derived OMVs (5 µg/ml, H) for 8 h, or treated with Pam3CSK4 (1 µg/ml, 3 h),
followed by the transfection of LPS (1 µg/ml, H; 2 µg/ml, I) for 6 h. (n = 3) Culture supernatants (Sup) or cellular lysates (Lys) were immunoblotted with the indicated
antibodies. Data were expressed as the mean ± SEM. Asterisks indicate significant differences compared with the group in the Nlrp3+/+ cells. (*P < 0.05,
***P < 0.001, n.s. not significant).November 2020 | Volume 11 | Article 581165
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the cytoplasm of host cells through T3SS-dependent direct
secretion and bacterial phagocytosis (22, 28). However, recent
studies found that flagellin is also detected in OMVs from S.
typhimurium and P. aeruginosa (29–31). In this context, OMV
cargo is capable of delivering bacterial flagellin into the cytoplasm
leading to intracellular NLRC4 inflammasome responses.
Our data demonstrate that heat treatment significantly reduced
inflammasome-stimulating potential of Salmonella CS, but not of
SalmonellaOMVs. Considering that heat treatment did not induce
flagellin degradation in the bacterial CS (Figure S1B), we speculate
that heat treatment may disrupt the conformation of flagellin or
prgJ, resulting in the attenuation of the ability to activate the
inflammasomes. In contrast, heat treatment slightly increased
Salmonella OMV-driven inflammasome activation. It is possible
that heat may cause a weak disruption of OMV structure,
facilitating more efficient delivery to the cytoplasm. These
findings suggest that OMVs can protect flagellin from heat-
induced damage during the delivery to the target cells.Frontiers in Immunology | www.frontiersin.org 10Somewhat different from the in vitro results in macrophages, in
vivo IL-1b production by S. typhimurium OMV was dependent on
both NLRC4 and NLRP3 after intraperitoneal challenge with
OMVs (Figure 6). These in vivo results suggest that Salmonella
OMV-bound LPS was also important for inflammasome activation
in the peritoneal lavage contents of mice. Both NLRC4 and NLRP3
are likely to be redundant for detecting Salmonella-derived OMVs
to trigger inflammasome responses, at least in peritoneal lavage
contents. Flagellin was the main stimulant for S. typhimurium
OMV-driven inflammasome activation in the BMDMs, but
flagellin-deficient S. typhimurium OMVs also triggered a slight
inflammasome activation in a NLRP3-dependent manner
(Figure 3D). However, we found that flagellin-deficient S.
typhimurium OMVs caused a delayed inflammasome response
in BMDMs compared with wild-type S. typhimurium OMVs
(Figure 6A). Furthermore, flagellated S. typhimurium OMVs
induced more rapid inflammasome activation than non-
flagellated E. coli OMVs in BMDMs (Figure 6D). These results
indicate that at least in macrophages, NLRC4 inflammasomeA B D E
F G IH J
C
FIGURE 5 | Salmonella-released outer membrane vesicles exhibit heat-resistant and GBP2-independent inflammasome activation potential. (A) Immunoblots of
OptiPrep density gradient fractions of S. typhimurium OMVs. (B) Immunoblots of the extracts of OMVs in the presence of heat treatment (97°C, 30 min) or
proteinase K treatment (10 µg/ml, 30 min) by anti-ST-flagellin antibody. (C) Immunoblots from mouse BMDMs primed with LPS (0.25 µg/ml, 3 h), followed by the
treatment with intact or heat-treated S. typhimurium flagellin (250 ng/ml) for 6 h. (D) Immunoblots of mouse BMDMs treated with intact or heat-treated S.
typhimurium OMVs (5 µg/ml) for 6 h. (E) Quantification of IL-1b in the culture supernatants of mouse BMDMs treated with intact or heat-treated S. typhimurium
OMVs for 6 h. (n = 5). (F) Immunoblots from Gbp2+/+ or Gbp2−/− mice BMDMs treated with E. coli BL21 OMVs (5 µg/ml) or S. typhimurium (14028s) OMVs (5 µg/ml)
or for 8 h. (G, H) Quantification of IL-1b in the culture supernatants of Gbp2+/+ or Gbp2−/− mice BMDMs treated as same as (F) (n = 3). (I, J) Immunoblots of mouse
BMDMs treated with intact or proteinase-treated S. typhimurium OMVs (10 µg/ml) in the presence of MCC 950 (100 nM) as indicated for 8 h. After proteinase
treatment, PMSF was added to eliminate proteinase K activity. Culture supernatants (Sup) or cellular lysates (Lys) were immunoblotted with the indicated antibodies.
Data were expressed as the mean ± SEM. Asterisks indicate significant differences. (**P < 0.01, ***P < 0.001, n.s. not significant).November 2020 | Volume 11 | Article 581165
Yang et al. NLRC4 Inflammasome Activation by OMVmachinery is a more rapid sensor for detecting Salmonella-
released OMVs than caspase-11. Particularly, NLRC4-mediated
pathogen sensing is crucial for host defense against enteric
infection, but not against intraperitoneal infection (10). In this
context, NLRC4 inflammasome signaling for flagellated bacteria-
released OMVs might have a major role in host defense,
especially in the gut.
GBPs, interferon-inducible GTPases, are required for
clearance of intracellular pathogens by inducing lysis of
pathogen-containing vacuoles (32–34). GBPs also facilitates the
intracellular interaction of OMV-bound LPS with caspase-11 by
exposing lipid A (19). Thus, GBPs have a pivotal role in non-
canonical inflammasome activation by OMVs. However, GBP2
seemed not to be critical for inflammasome activation by S.
typhimurium-released OMVs (Figure 5H). These results
indicated that GBP2 was not involved in activation of NLRC4
inflammasome signaling by OMV-associated flagellin. The
precise role of other GBPs for OMV-mediated NLRC4
inflammasome requires further investigation.Frontiers in Immunology | www.frontiersin.org 11A physiological significance of NLRC4 inflammasome activation
by bacterial OMVs remains to be further determined. Based on
previous studies and our present results, both caspase-11 non-
canonical and NLRC4 canonical inflammasomes promote caspase-
1-dependent IL-1b production in response to bacteria-released
OMVs (Figure 7). Interestingly, both caspase-11-deficient and
Gbp-deficient mice showed increased survival after poly I:C and
the subsequent E. coli OMV injection (19). This finding indicates
that caspase-11 non-canonical inflammasome activation by E. coli
OMV-associated LPS significantly contributes to endotoxic shock
via inducing a robust pyroptosis. Instead, NLRC4 inflammasome
signaling by flagellated bacteria-released OMVs can contribute to
rapid detection of bacterial infection leading to the inhibition of
bacterial dissemination and virulence as a host defense mechanism
(Figure 7). Taken together, our findings suggest that NLRC4 is a
bona-fide sensor for detecting flagellated bacteria-released OMVs to
mediate inflammasome signaling. These results provide molecular
insights into host defense mechanisms against flagellin-containing
bacterial pathogens such as S. typhimurium or P. aeruginoasa.A B D E
F G IH J
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FIGURE 6 | Salmonella-released outer membrane vesicles trigger in vivo NLRC4-dependent interleukin-1b secretion. (A) Immunoblots from mouse BMDMs treated
with wild-type (WT) or DfliC–fljB S. typhimurium (SL1344) OMV (5 µg/ml) for 2, 4, 8 h. (B) Quantification of IL-1b in the culture supernatants of mouse BMDMs treated
with WT or DfliC–fljB S. typhimurium (SL1344) OMVs (5 µg/ml) for 2, 8, 16 h. (n = 3) (C) Quantification of LDH release into culture supernatants of mouse BMDMs
treated with WT or DfliC–fljB S. typhimurium (SL1344) OMVs (5 µg/ml) for 2, 8, 16 h. (n = 3) (D) Immunoblots from mouse BMDMs treated with S. typhimurium
(SL1344) or E. coli (BL21) OMVs (5 µg/ml) for 2, 4, 8 h as indicated. GSDMD, gasdermin D (E) Quantification of LDH release into culture supernatants of mouse
BMDMs treated with S. typhimurium (SL1344) or E. coli (BL21) OMVs (5 µg/ml) for 2, 4, 8 h as indicated. (n = 3). (F, G) Quantification of IL-1b in the peritoneal
lavage fluid of Nlrc4+/+ or Nlrc4−/− (F), or Nlrp3+/+ or Nlrp3−/− (G) mice 6 h after intraperitoneal injection of PBS or S. typhimurium OMVs (50 µg/mice). (n = 2, PBS;
n = 3, OMV) (H) Quantification of IL-1b in the peritoneal lavage fluid of Nlrp3+/+ or Nlrp3−/− mice 6 h after intraperitoneal injection of DfliC–fljB S. typhimurium OMVs
(50 µg/mice). (n = 5, Nlrp3+/+; n = 6, Nlrp3−/−) (I, J) Quantification of IL-6 in the peritoneal lavage fluid of Nlrc4+/+ or Nlrc4−/− (I), or Nlrp3+/+ or Nlrp3−/− (J) mice 6 h
after intraperitoneal injection of PBS or S. typhimurium OMVs (50 µg/mice). (n = 2, PBS; n = 3, OMV) Culture supernatants (Sup) or cellular lysates (Lys) were
immunoblotted with the indicated antibodies. Data were expressed as the mean ± SEM. Asterisks indicate significant differences. (*P < 0.05, ***P < 0.001, n.s. not
significant).November 2020 | Volume 11 | Article 581165
Yang et al. NLRC4 Inflammasome Activation by OMVDATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation.ETHICS STATEMENT
The animal study was reviewed and approved by Institutional
Ethical Committee, Yonsei University College of Medicine.AUTHOR CONTRIBUTIONS
JY designed and conducted most of the experiments in this study.
IH and EL conducted the experiments. SS, E-JL, and JR provided
critical materials and technical advice. J-WY supervised the
entire project and wrote the manuscript with JY. All authors
contributed to the article and approved the submitted version.Frontiers in Immunology | www.frontiersin.org 12FUNDING
This work was supported by the National Research Foundation of
Korea Grant funded by the Korean Government (2015M3A9
B6073856, 2017R1A2B2007467, 2020R1A2B5B02001823).ACKNOWLEDGMENTS
We would like to thank F. Shao (National Institute of Biological
Sciences, China) for providing S. typhimurium mutants, and S.J.
Oh and O.S. Shin (Korea University) for the help of Nanoparticle
Tracking Analysis.SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at: https://www.frontiersin.org/articles/10.3389/fimmu.2020.
581165/full#supplementary-materialFIGURE 7 | Proposed mechanism of host inflammasome activation by flagellated or non-flagellated bacteria-released outer membrane vesicles. Flagellated bacteria
such as S. typhimurium or P. aeruginosa facilitate the delivery of bacterial flagellin and LPS into the cytoplasm of host cells via OMV cargo. In the initial phase of OMV
exposure, OMV-delivered flagellin causes the assembly of NLRC4 inflammasome leading to caspase-1 activation and the subsequent IL-1b secretion. Besides flagellin,
intracellular OMV-associated LPS can activate caspase-11 non-canonical inflammasome signaling, which includes GSDMD-dependent pyroptosis and NLRP3-mediated
caspase-1 activation and IL-1b secretion. On the contrary, OMVs derived from non-flagellated bacteria such as E. coli mediates the cytosolic delivery of bacterial LPS.
Non-flagellated bacterial -delivered LPS mainly causes the activation of caspase-11 and GSDMD-mediated pyroptosis, contributing to potential endotoxic shock.
NAIP5, NLR family, apoptosis inhibitory protein 5; NLRC4, NLR family, CARD domain-containing protein 4; NLRP3, NLR family, pyrin domain-containing protein 3;
GSDMD, gasdermin D.November 2020 | Volume 11 | Article 581165
Yang et al. NLRC4 Inflammasome Activation by OMVREFERENCES
1. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell
(2010) 140(6):805–20. doi: 10.1016/j.cell.2010.01.022
2. Storek KM, Monack DM. Bacterial recognition pathways that lead to
inflammasome activation. Immunol Rev (2015) 265(1):112–29.
doi: 10.1111/imr.12289
3. Sahoo M, Ceballos-Olvera I, del Barrio L, Re F. Role of the inflammasome, IL-
1beta, and IL-18 in bacterial infections. ScientificWorldJournal (2011)
11:2037–50. doi: 10.1100/2011/212680
4. Yu JW, Lee MS. Mitochondria and the NLRP3 inflammasome: physiological
and pathological relevance. Arch Pharm Res (2016) 39(11):1503–18.
doi: 10.1007/s12272-016-0827-4
5. Broz P. Recognition of Intracellular Bacteria by Inflammasomes. Microbiol
Spectr (2019) 7(2):BAI-0003-2019. doi: 10.1128/microbiolspec.BAI-0003-2019
6. Duncan JA, Canna SW. The NLRC4 Inflammasome. Immunol Rev (2018) 281
(1):115–23. doi: 10.1111/imr.12607
7. Zhao Y, Yang J, Shi J, Gong YN, Lu Q, Xu H, et al. The NLRC4 inflammasome
receptors for bacterial flagellin and type III secretion apparatus. Nature (2011)
477(7366):596–600. doi: 10.1038/nature10510
8. Yang J, Zhao Y, Shi J, Shao F. Human NAIP and mouse NAIP1 recognize
bacterial type III secretion needle protein for inflammasome activation.
Proc Natl Acad Sci U S A (2013) 110(35):14408–13. doi: 10.1073/
pnas.1306376110
9. Zhang L, Chen S, Ruan J, Wu J, Tong AB, Yin Q, et al. Cryo-EM structure of
the activated NAIP2-NLRC4 inflammasome reveals nucleated
polymerization. Science (2015) 350(6259):404–9. doi: 10.1126/
science.aac5789
10. Franchi L, Kamada N, Nakamura Y, Burberry A, Kuffa P, Suzuki S, et al.
NLRC4-driven production of IL-1beta discriminates between pathogenic and
commensal bacteria and promotes host intestinal defense. Nat Immunol
(2012) 13(5):449–56. doi: 10.1038/ni.2263
11. Man SM, Hopkins LJ, Nugent E, Cox S, Gluck IM, Tourlomousis P, et al.
Inflammasome activation causes dual recruitment of NLRC4 and NLRP3 to
the same macromolecular complex. Proc Natl Acad Sci U S A (2014) 111
(20):7403–8. doi: 10.1073/pnas.1402911111
12. Fernandes-Alnemri T, Yu JW, Juliana C, Solorzano L, Kang S, Wu J, et al. The
AIM2 inflammasome is critical for innate immunity to Francisella tularensis.
Nat Immunol (2010) 11(5):385–93. doi: 10.1038/ni.1859
13. Hagar JA, Powell DA, Aachoui Y, Ernst RK, Miao EA. Cytoplasmic LPS
activates caspase-11: implications in TLR4-independent endotoxic shock.
Science (2013) 341(6151):1250–3. doi: 10.1126/science.1240988
14. Kayagaki N, Wong MT, Stowe IB, Ramani SR, Gonzalez LC, Akashi-
Takamura S, et al. Noncanonical inflammasome activation by intracellular
LPS independent of TLR4. Science (2013) 341(6151):1246–9. doi: 10.1126/
science.1240248
15. Park YH, Wood G, Kastner DL, Chae JJ. Pyrin inflammasome activation and
RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat
Immunol (2016) 17(8):914–21. doi: 10.1038/ni.3457
16. Schwechheimer C, Kuehn MJ. Outer-membrane vesicles from Gram-negative
bacteria: biogenesis and functions. Nat Rev Microbiol (2015) 13(10):605–19.
doi: 10.1038/nrmicro3525
17. Pathirana RD, Kaparakis-Liaskos M. Bacterial membrane vesicles: Biogenesis,
immune regulation and pathogenesis. Cell Microbiol (2016) 18(11):1518–24.
doi: 10.1111/cmi.12658
18. Vanaja SK, Russo AJ, Behl B, Banerjee I, Yankova M, Deshmukh SD, et al.
Bacterial Outer Membrane Vesicles Mediate Cytosolic Localization of LPS
and Caspase-11 Activation. Cell (2016) 165(5):1106–19. doi: 10.1016/
j.cell.2016.04.015
19. Santos JC, Dick MS, Lagrange B, Degrandi D, Pfeffer K, Yamamoto M, et al.
LPS targets host guanylate-binding proteins to the bacterial outer membrane
for non-canonical inflammasome activation. EMBO J (2018) 37(6):e98089.
doi: 10.15252/embj.201798089Frontiers in Immunology | www.frontiersin.org 1320. Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES. AIM2 activates the
inflammasome and cell death in response to cytoplasmic DNA. Nature (2009)
458(7237):509–13. doi: 10.1038/nature07710
21. Gim E, Shim DW, Hwang I, Shin OS, Yu JW. Zika Virus Impairs Host
NLRP3-mediated Inflammasome Activation in an NS3-dependent Manner.
Immune Netw (2019) 19(6):e40. doi: 10.4110/in.2019.19.e40
22. Franchi L, Amer A, Body-Malapel M, Kanneganti TD, Ozoren N, Jagirdar R,
et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and
interleukin 1beta in salmonella-infected macrophages. Nat Immunol (2006)
7(6):576–82. doi: 10.1038/ni1346
23. Kofoed EM, Vance RE. Innate immune recognition of bacterial ligands by
NAIPs determines inflammasome specificity. Nature (2011) 477(7366):592–5.
doi: 10.1038/nature10394
24. Finethy R, Luoma S, Orench-Rivera N, Feeley EM, Haldar AK, Yamamoto M,
et al. Inflammasome Activation by Bacterial Outer Membrane Vesicles
Requires Guanylate Binding Proteins. MBio (2017) 8(5):e01188-17.
doi: 10.1128/mBio.01188-17
25. Chen S, Yang D, Wen Y, Jiang Z, Zhang L, Jiang J, et al. Dysregulated
hemolysin liberates bacterial outer membrane vesicles for cytosolic
lipopolysaccharide sensing. PLoS Pathog (2018) 14(8):e1007240.
doi: 10.1371/journal.ppat.1007240
26. Kayagaki N, Stowe IB, Lee BL, O’Rourke K, Anderson K, Warming S, et al.
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling.
Nature (2015) 526(7575):666–71. doi: 10.1038/nature15541
27. Matsui H, Eguchi M, Ohsumi K, Nakamura A, Isshiki Y, Sekiya K, et al.
Azithromycin inhibits the formation offlagellar filaments without suppressing
flagellin synthesis in Salmonella enterica serovar typhimurium. Antimicrob
Agents Chemother (2005) 49(8):3396–403. doi: 10.1128/AAC.49.8.3396-
3403.2005
28. Mariathasan S, Newton K, Monack DM, Vucic D, French DM, Lee WP, et al.
Differential activation of the inflammasome by caspase-1 adaptors ASC and
Ipaf. Nature (2004) 430(6996):213–8. doi: 10.1038/nature02664
29. Liu Q, Liu Q, Yi J, Liang K, Hu B, Zhang X, et al. Outer membrane vesicles
from flagellin-deficient Salmonella enterica serovar Typhimurium induce
cross-reactive immunity and provide cross-protection against heterologous
Salmonella challenge. Sci Rep (2016) 6:34776. doi: 10.1038/srep34776
30. Bai J, Kim SI, Ryu S, Yoon H. Identification and characterization of outer
membrane vesicle-associated proteins in Salmonella enterica serovar
Typhimurium. Infect Immun (2014) 82(10):4001–10. doi: 10.1128/
IAI.01416-13
31. Bauman SJ, Kuehn MJ. Purification of outer membrane vesicles from
Pseudomonas aeruginosa and their activation of an IL-8 response. Microbes
Infect (2006) 8(9-10):2400–8. doi: 10.1016/j.micinf.2006.05.001
32. Meunier E, Dick MS, Dreier RF, Schurmann N, Kenzelmann Broz D,
Warming S, et al. Caspase-11 activation requires lysis of pathogen-
containing vacuoles by IFN-induced GTPases. Nature (2014) 509
(7500):366–70. doi: 10.1038/nature13157
33. Meunier E, Wallet P, Dreier RF, Costanzo S, Anton L, Ruhl S, et al. Guanylate-
binding proteins promote activation of the AIM2 inflammasome during
infection with Francisella novicida. Nat Immunol (2015) 16(5):476–84.
doi: 10.1038/ni.3119
34. Rathinam VAK, Zhao Y, Shao F. Innate immunity to intracellular LPS. Nat
Immunol (2019) 20(5):527–33. doi: 10.1038/s41590-019-0368-3
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Yang, Hwang, Lee, Shin, Lee, Rhee and Yu. This is an open-access
article distributed under the terms of the Creative Commons Attribution License
(CC BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice. No
use, distribution or reproduction is permitted which does not comply with these terms.November 2020 | Volume 11 | Article 581165
